Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 84

Results For "Pan"

9151 News Found

Medtronic secures CE Mark for Stealth AXiS surgical navigation system in Europe
Medical Device | June 09, 2026

Medtronic secures CE Mark for Stealth AXiS surgical navigation system in Europe

New-generation platform enhances anatomical visualization, streamlines surgical workflows, and expands access to advanced navigation technology for ENT surgeons across Europe


Yashoda Medicity gets DGME approval for brain stem death certification committee
Hospitals | June 09, 2026

Yashoda Medicity gets DGME approval for brain stem death certification committee

The newly constituted committee will facilitate timely brain stem death certification, supporting transparent organ donation processes and expanding opportunities for patients awaiting transplants


AbbVie showcases broad blood cancer pipeline at EHA 2026 with 21 presentations
Clinical Trials | June 09, 2026

AbbVie showcases broad blood cancer pipeline at EHA 2026 with 21 presentations

The company will present 21 oral and poster presentations spanning investigational and approved therapies


Merck appoints Clara Sattler de Sousa e Brito and Robert Machinek to key leadership roles
People | June 09, 2026

Merck appoints Clara Sattler de Sousa e Brito and Robert Machinek to key leadership roles

Clara Sattler de Sousa e Brito to lead discovery solutions from Q3 2026, while Robert Machinek takes over as Head of Strategy & Business Development


Eli Lilly's oral weight-loss drug shows major fat loss across stages of menopause in trials
Clinical Trials | June 09, 2026

Eli Lilly's oral weight-loss drug shows major fat loss across stages of menopause in trials

The results come from post-hoc analyses of more than 1,500 women enrolled in the Phase 3 ATTAIN-1 and ATTAIN-2 trials, presented at the American Diabetes Association’s 86th Scientific Sessions


AstraZeneca reports major Phase III breakthrough in IgA kidney disease trial
Clinical Trials | June 09, 2026

AstraZeneca reports major Phase III breakthrough in IgA kidney disease trial

At 34 weeks, Ultomiris achieved a 43.4% placebo-adjusted reduction in 24-hour urine protein creatinine ratio (UPCR) versus placebo, meeting the study’s key interim endpoint


ShardaCare provides medical support at 30th Pre-UP State Shooting Championship 2026
Hospitals | June 09, 2026

ShardaCare provides medical support at 30th Pre-UP State Shooting Championship 2026

As official healthcare partner, ShardaCare deployed dedicated medical teams, emergency services, and on-site healthcare infrastructure


FUJIFILM brings next-gen AI-enabled digital mammography platform to India
Medical Device | June 09, 2026

FUJIFILM brings next-gen AI-enabled digital mammography platform to India

First installation of AI-powered AMULET SOPHINITY at NM Medical aims to strengthen early breast cancer detection


Lilly’s oral GLP-1 drug Orforglipron outperforms Semaglutide in phase 3 diabetes trial
News | June 09, 2026

Lilly’s oral GLP-1 drug Orforglipron outperforms Semaglutide in phase 3 diabetes trial

Based on the cumulative data from ACHIEVE-1 through ACHIEVE-5, Lilly plans to submit orforglipron for FDA approval for the treatment of type 2 diabetes by the end of the second quarter